TP53 and neoplasm: Despite regulating both pro-arrest and pro-apoptotic targets simultaneously, Nutlin-3A-mediated MDM2 inhibition typically results in p53-dependent cell-cycle arrest rather than cell death, in all but MDM2-amplified tumours such as liposarcoma [220].